New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 4, 2012
10:00 EDTLVS, TDW, HOS, THS, SBUX, LGP, DNKN, CBOU, ALXA, THI, TD, NCS, IMPV, DSW, BNS, CLB, RY, MDVN, FLS, GLW, ALEOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Alexza Pharmaceuticals (ALXA) initiated with a Buy at Roth Capital... Allete (ALE) initiated with a Buy at KeyBanc... Bank of Nova Scotia (BNS) initiated with a Neutral at Citigroup... Caribou Coffee (CBOU) initiated with a Buy at Longbow... Corning (GLW) initiated with an Outperform at Bernstein... DSW Inc. (DSW) initiated with an Outperform at William Blair... Dunkin' Brands (DNKN) initiated with a Buy at Longbow... Flowserve (FLS) initiated with a Buy at KeyBanc... Imperva (IMPV) initiated with an Outperform at Oppenheimer... Lehigh Gas (LGP) initiated with a Buy at Janney Capital... Lehigh Gas (LGP) initiated with an Outperform at RW Baird... Medivation (MDVN) initiated with an Equal Weight at Barclays... NCI Building Systems (NCS) initiated with an Outperform at FBR Capital... Royal Bank of Canada (RY) initiated with a Buy at Citigroup... Starbucks (SBUX) initiated with a Buy at Longbow... Toronto-Dominion (TD) initiated with a Buy at Citigroup... TreeHouse Foods (THS) initiated with a Buy at Longbow... Tim Hortons (THI) initiated with a Buy at Longbow... Core Laboratories (CLB) initiated with a Buy at Global Hunter... Las Vegas Sands (LVS) initiated with a Buy at Craig-Hallum... Hornbeck Offshore (HOS) coverage resumed with a Neutral at Goldman... Tidewater (TDW) coverage resumed with a Neutral at Goldman.
News For ALXA;ALE;BNS;CBOU;GLW;DSW;DNKN;FLS;IMPV;LGP;MDVN;NCS;SBUX;RY;TD;THS;CLB;THI;LVS;HOS;TDW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 20, 2015
08:18 EDTSBUXKeurig Green Mountain downgraded at Argus on 2.0 brewer challenges
Subscribe for More Information
07:40 EDTDNKNDunkin' Brands' California launch still not going well, says Longbow
Subscribe for More Information
06:29 EDTBNSBank of Nova Scotia downgraded to Underperform from Neutral at BofA/Merrill
May 19, 2015
16:45 EDTRYCity National reaches tentative settlement in shareholder dispute of RBC merger
Subscribe for More Information
May 18, 2015
17:07 EDTSBUXStarbucks establishes music partnership with Spotify
Subscribe for More Information
10:01 EDTLVSOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:00 EDTSBUXStarbucks management to meet with JPMorgan
Subscribe for More Information
07:40 EDTLVSLas Vegas Sands downgraded to Neutral from Buy at Goldman
Subscribe for More Information
May 17, 2015
12:53 EDTMDVNMedivation, Astellas report enzalutamide study met primary endpoint
Subscribe for More Information
May 15, 2015
12:28 EDTTDWTidewater extends common stock repurchase program through June 30, 2016
Subscribe for More Information
08:36 EDTALEAllete says MPUC approves Minnesota Power's request for CN
Subscribe for More Information
07:35 EDTMDVNMedivation price target raised to $148 from $128 at Leerink
Subscribe for More Information
07:14 EDTIMPVPiper recommends buying shares of Imperva
Subscribe for More Information
05:43 EDTLVSWynn Resorts downgraded to Equal Weight from Overweight at Barclays
Subscribe for More Information
May 14, 2015
10:00 EDTNCSOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:56 EDTIMPVImperva outlook has improved, says RBC Capital
After marketing with Imperva's management, RBC Capital is more upbeat on the company's outlook. The firm thinks Imperva's management looks confident, while its end market has improved and it remains well-positioned within the sector. RBC keeps a $61 price target and Outperform rating on the shares.
07:53 EDTNCSNCI Building upgraded to Buy from Neutral at DA Davidson
Subscribe for More Information
07:07 EDTMDVNMedivation to present data in TNBC at ASCO
Medivation announced that the following abstract will be presented during an oral presentation at the 2015 American Society of Clinical Oncology, or ASCO, Annual Meeting on June 1, in Chicago: Results from a phase 2 study of enzalutamide, an androgen receptor, or AR, inhibitor, in advanced AR+ triple-negative breast cancer, or TNBC.
06:46 EDTIMPVImperva price target raised to $66 from $57 at Piper Jaffray
Piper Jaffray raised its price target for Imperva to $66 after meetings with management gave it increased conviction in the company's Q2 results as well as its longer-term belief that the company is one of the best positioned vendors. Piper views the stock's valuation as "relatively cheap" and reiterates an Overweight rating on the name.
May 13, 2015
09:35 EDTLVSLas Vegas Sands' Q1 revenues tracking slightly below Street, says ITG Research
ITG Research said Las Vegas Sands' Q1 net revenues are tracking in the range of $2.95B-$3B, below consensus of $3.03B.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use